Drug intelligence / Profile preview

6-monoacetylmorphine

Development stage
Unknown
Lead developer
Universitätsklinikum Freiburg
Modality
Small Molecules
Administration
Intravenous, Intraperitoneal
01

Overview

6-Monoacetylmorphine (6-MAM) is a potent small molecule opioid and a primary active metabolite of heroin (diacetylmorphine). It is formed rapidly in the body via deacetylation of heroin and is subsequently metabolized into morphine. 6-MAM is significantly more potent than morphine and is responsible for much of the rapid onset of heroin's effects. Because it is not produced from other opioids like codeine or morphine, its presence in biological samples serves as a definitive forensic biomarker for heroin consumption. It acts as an agonist at opioid receptors in the central nervous system. While not developed as a therapeutic agent, it is utilized in forensic research, such as studies by Universitätsklinikum Freiburg investigating drug deposition in dental biofilms.

Other names
6-acetylmorphine
02

Targets

KOR (Kappa opioid receptor)DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on 6-monoacetylmorphine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 6-monoacetylmorphine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call